CSJ117

· Novartis Pharmaceuticals

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for CSJ117, covering 2022-11-28 to 2023-08-07. Get the full timeline:

Most recent: Clinical Trial Update: Study of Efficacy and Safety of CSJ117 in Patients With Severe Uncontrolled Asthma [Phase 2]